US FDA approves two gene therapies to target sickle cell disease
U.S FDA has approved two groundbreaking gene therapies targeting sickle cell disease, marking a significant milestone in the realm of ...
U.S FDA has approved two groundbreaking gene therapies targeting sickle cell disease, marking a significant milestone in the realm of ...
A drug named Crizanlizumab, produced by Novartis has been approved for Sickle Cell treatment in England by the National Health ...
Business News | Stock Market | Money Market | Cryptos | Financial Literacy | SME |